Sep 10, 2013
Sensus Healthcare is proud to announce their newest introduction for non-melanoma skin cancer treatment at the 55th annual American Society of Therapeutic Radiation Oncology in Atlanta, GA. on...
Aug 28, 2013
Sensus Healthcare is pleased to announce Dr. Mark Nestor as Clinical Director. Dr. Nestor joins a distinguished panel of Medical Advisory Board Members. He will lead the Company's efforts in the...
Jul 27, 2013
The Food and Drug Administration (FDA) has recently gave Sensus Healthcare the clearance to use its revolutionary product, the SRT-100, the green signal t treat hypertrophic scars and keloid...
Jul 15, 2013
Sensus Healthcare is pleased to announce Dr. Clay Cockerell as Medical Director. Dr. Cockerell will lead the distinguished members of the Medical Advisory Board as the Company continues to provide...
May 24, 2013
Sensus Healthcare is pleased to announce that it has received clearance from the U.S. Food and Drug Administration to treat Keloids with the SRT-100™. The SRT-100™ is the leading alternative...